Compound class:
Synthetic organic
Comment: Compound 4k is reported to completely block currents through the Orai component of the calcium release activated calcium (CRAC) channel, evaluated as inhibition of NFAT activation and nuclear translocation [1]. Blockade of Orai pore was confirmed in HEK293 cells overexpressing G98S mutant or wild-type Orai1. Compound 4k does not alter the electrophysiological function of TRPM4 and TRPM7 channels. The chemical structure is claimed in patent WO2020180876A1 [2].
|
|
References |
1. Liardo E, Pham AT, Ghilardi AF, Zhelay T, Szteyn K, Gandi NL, Ekkati A, Koerner S, Kozak JA, Sun L. (2024)
Discovery of selective Orai channel blockers bearing an indazole or a pyrazole scaffold. Eur J Med Chem, 278: 116805. [PMID:39232360] |
2. Sun L. (2020)
Orai channel inhibitors. Patent number: WO2020180876A1. Assignee: Beth Israel Deaconess Medical Center, Inc.. Priority date: 03/03/2020. Publication date: 10/09/2020. |